These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 17225468)
1. Synthesis, characterization and in vitro evaluation of triptolide-lysozyme conjugate for renal targeting delivery of triptolide. Zheng Q; Gong T; Sun X; Zhang ZR Arch Pharm Res; 2006 Dec; 29(12):1164-70. PubMed ID: 17225468 [TBL] [Abstract][Full Text] [Related]
2. The targeting of 14-succinate triptolide-lysozyme conjugate to proximal renal tubular epithelial cells. Zhang Z; Zheng Q; Han J; Gao G; Liu J; Gong T; Gu Z; Huang Y; Sun X; He Q Biomaterials; 2009 Mar; 30(7):1372-81. PubMed ID: 19100618 [TBL] [Abstract][Full Text] [Related]
3. Kinetic release of triptolide after injection of renal-targeting 14-succinyl triptolide-lysozyme in a rat kidney study by liquid chromatography/mass spectrometry. Zheng Q; Ye L; Gao R; Han J; Xiong M; Zhao D; Gong T; Zhang Z Biomed Chromatogr; 2007 Jul; 21(7):724-9. PubMed ID: 17370252 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, Characterization, and Evaluation of Triptolide Cell-Penetrating Peptide Derivative for Transdermal Delivery of Triptolide. Tian T; Song Y; Li K; Sun Y; Wang Q Mol Pharm; 2018 Feb; 15(2):560-570. PubMed ID: 29307194 [TBL] [Abstract][Full Text] [Related]
5. Renal targeted delivery of triptolide by conjugation to the fragment peptide of human serum albumin. Yuan ZX; Wu XJ; Mo J; Wang YL; Xu CQ; Lim LY Eur J Pharm Biopharm; 2015 Aug; 94():363-71. PubMed ID: 26117184 [TBL] [Abstract][Full Text] [Related]
6. Renal-targeted delivery of triptolide by entrapment in pegylated TRX-20-modified liposomes. Yuan ZX; Jia L; Lim LY; Lin JC; Shu G; Zhao L; Ye G; Liang XX; Ji H; Fu HL Int J Nanomedicine; 2017; 12():5673-5686. PubMed ID: 28848346 [TBL] [Abstract][Full Text] [Related]
7. Effect of poly(D, L-lactic acid) nanoparticles as triptolide carrier on abating rats renal toxicity by NMR-based metabolic analysis. Liu M; Dong J; Yang Y; Yang X; Xu H J Nanosci Nanotechnol; 2008 Jul; 8(7):3493-9. PubMed ID: 19051901 [TBL] [Abstract][Full Text] [Related]
8. Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats. Xue M; Zhao Y; Li XJ; Jiang ZZ; Zhang L; Liu SH; Li XM; Zhang LY; Yang SY Eur J Pharm Sci; 2012 Nov; 47(4):713-7. PubMed ID: 22677813 [TBL] [Abstract][Full Text] [Related]
9. A renal-targeted triptolide aminoglycoside (TPAG) conjugate for lowering systemic toxicities of triptolide. Qi B; Wang X; Zhou Y; Han Q; He L; Gong T; Sun X; Fu Y; Zhang Z Fitoterapia; 2015 Jun; 103():242-51. PubMed ID: 25869848 [TBL] [Abstract][Full Text] [Related]
10. Fabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis. Zhang L; Chang J; Zhao Y; Xu H; Wang T; Li Q; Xing L; Huang J; Wang Y; Liang Q Int J Nanomedicine; 2018; 13():2051-2064. PubMed ID: 29670349 [TBL] [Abstract][Full Text] [Related]
11. Kidney-targeted triptolide-encapsulated mesoscale nanoparticles for high-efficiency treatment of kidney injury. Deng X; Zeng T; Li J; Huang C; Yu M; Wang X; Tan L; Zhang M; Li A; Hu J Biomater Sci; 2019 Dec; 7(12):5312-5323. PubMed ID: 31617509 [TBL] [Abstract][Full Text] [Related]
12. Anti-tumour and immuno-modulation effects of triptolide-loaded polymeric micelles. Xu L; Chen H; Xu H; Yang X Eur J Pharm Biopharm; 2008 Nov; 70(3):741-8. PubMed ID: 18761405 [TBL] [Abstract][Full Text] [Related]
13. Triptolide-targeted delivery methods. Xu H; Liu B Eur J Med Chem; 2019 Feb; 164():342-351. PubMed ID: 30605832 [TBL] [Abstract][Full Text] [Related]
14. The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle. Mei Z; Li X; Wu Q; Hu S; Yang X Pharmacol Res; 2005 Apr; 51(4):345-51. PubMed ID: 15683748 [TBL] [Abstract][Full Text] [Related]
15. Triptolide alters barrier function in renal proximal tubular cells in rats. Sun L; Li H; Huang X; Wang T; Zhang S; Yang J; Huang S; Mei H; Jiang Z; Zhang L Toxicol Lett; 2013 Oct; 223(1):96-102. PubMed ID: 24008046 [TBL] [Abstract][Full Text] [Related]
16. Male reproductive toxicity and toxicokinetics of triptolide in rats. Ni B; Jiang Z; Huang X; Xu F; Zhang R; Zhang Z; Tian Y; Wang T; Zhu T; Liu J; Zhang L Arzneimittelforschung; 2008; 58(12):673-80. PubMed ID: 19202740 [TBL] [Abstract][Full Text] [Related]
17. Liquid chromatographic/mass spectrometry assay of triptolide in dog plasma and its application to pharmacokinetic study. Shao F; Wang G; Sun J; Xie H; Li H; Liang Y; Zhang R; Zhu X J Pharm Biomed Anal; 2006 May; 41(2):341-6. PubMed ID: 16413988 [TBL] [Abstract][Full Text] [Related]
18. Drug-targeting to the kidney: renal delivery and degradation of a naproxen-lysozyme conjugate in vivo. Haas M; Kluppel AC; Wartna ES; Moolenaar F; Meijer DK; de Jong PE; de Zeeuw D Kidney Int; 1997 Dec; 52(6):1693-9. PubMed ID: 9407519 [TBL] [Abstract][Full Text] [Related]
19. Targeted Delivery and Sustained Antitumor Activity of Triptolide through Glucose Conjugation. He QL; Minn I; Wang Q; Xu P; Head SA; Datan E; Yu B; Pomper MG; Liu JO Angew Chem Int Ed Engl; 2016 Sep; 55(39):12035-9. PubMed ID: 27574181 [TBL] [Abstract][Full Text] [Related]
20. Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo. Zhang L; Wang T; Li Q; Huang J; Xu H; Li J; Wang Y; Liang Q Int J Nanomedicine; 2016; 11():2663-73. PubMed ID: 27354796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]